Prion protein modulates monoaminergic systems and depressive-like behavior in mice

Journal of Biological Chemistry

Volumn 290, Issue 33, 2015, Pages 20488-20498

  Beckman, Danielle ^a   Santos, Luis E ^a   Americo, Tatiana A ^a   Ledo, Jose H ^a   De Mello, Fernando G ^a   Linden, Rafael ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

AMINES; AMINO ACIDS; NEURODEGENERATIVE DISEASES; NEUROPHYSIOLOGY; PROTEINS; SCAFFOLDS (BIOLOGY);

ALZHEIMER DISEASE; CEREBRAL CORTEX; CLINICAL DEPRESSION; COLOCALIZATION; NEURODEGENERATIVE DISORDERS; SEROTONIN RECEPTORS; SIGNALING SYSTEMS; TYROSINE HYDROXYLASE;

MAMMALS;

CYCLIC AMP; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 4 RECEPTOR; NORADRENALIN; PRION PROTEIN; SEROTONIN; SEROTONIN 5A RECEPTOR; TYROSINE 3 MONOOXYGENASE; BIOGENIC AMINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; DEPRESSION; FORCED SWIM TEST; MALE; MONOAMINERGIC SYSTEM; MOUSE; NONHUMAN; OPEN FIELD TEST; PRIORITY JOURNAL; ROTAROD TEST; ANIMAL; ANIMAL BEHAVIOR; C57BL MOUSE; GENETICS; KNOCKOUT MOUSE; PATHOPHYSIOLOGY; PHYSIOLOGY;

MUS;

ANIMALS; BEHAVIOR, ANIMAL; BIOGENIC MONOAMINES; DEPRESSION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PRPC PROTEINS;

EID: 84939631978     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M115.666156     Document Type: Article

References (107)

1. Prusiner, S. B. (1998) Prions. Proc. Natl. Acad. Sci. U.S.A. 95, 13363-13383
2. Aguzzi, A., and Calella, A. M. (2009) Prions: protein aggregation and infectious diseases. Physiol. Rev. 89, 1105-1152
3. Bolton, D. C., McKinley, M. P., and Prusiner, S. B. (1982) Identification of a protein that purifies with the scrapie prion. Science 218, 1309-1311
4. Smirnovas, V., Baron, G. S., Offerdahl, D. K., Raymond, G. J., Caughey, B., and Surewicz, W. K. (2011) Structural organization of brain-derived mammalian prions examined by hydrogen-deuterium exchange. Nat. Struct. Mol. Biol. 18, 504-506
5. Linden, R., Martins, V. R., Prado, M. A., Cammarota, M., Izquierdo, I., and Brentani, R. R. (2008) Physiology of the prion protein. Physiol. Rev. 88, 673-728
6. Mehrpour, M., and Codogno, P. (2010) Prion protein: from physiology to cancer biology. Cancer Lett. 290, 1-23
7. Laurén, J. (2014) Cellular prion protein as a therapeutic target in Alzheimer's disease. J. Alzheimers Dis. 38, 227-244
8. Magalhães, A. C., Silva, J. A., Lee, K. S., Martins, V. R., Prado, V. F., Ferguson, S. S., Gomez, M. V., Brentani, R. R., and Prado, M. A. (2002) Endocytic intermediates involved with the intracellular trafficking of a fluorescent cellular prion protein. J. Biol. Chem. 277, 33311-33318
9. Morris, R. J., Parkyn, C. J., and Jen, A. (2006) Traffic of prion protein between different compartments on the neuronal surface, and the propagation of prion disease. FEBS Lett. 580, 5565-5571
10. Linden, R., Cordeiro, Y., and Lima, L. (2012) Allosteric function and dysfunction of the prion protein. Cell. Mol. Life Sci. 69, 1105-1124
11. Onodera, T., Sakudo, A., Tsubone, H., and Itohara, S. (2014) Review of studies that have used knockout mice to assess normal function of prion protein under immunological or pathophysiological stress. Microbiol. Immunol. 58, 361-374
12. Mariante, R. M., Nóbrega, A., Martins, R. A., Areal, R. B., Bellio, M., and Linden, R. (2012) Neuroimmunoendocrine regulation of the prion protein in neutrophils. J. Biol. Chem. 287, 35506-35515
13. Martin-Lannerée, S., Hirsch, T. Z., Hernandez-Rapp, J., Halliez, S., Vilotte, J. L., Launay, J. M., and Mouillet-Richard, S. (2014) PrP(C) from stem cells to cancer. Front. Cell Dev. Biol. 2, 55
14. Zanetti, F., Carpi, A., Menabò, R., Giorgio, M., Schulz, R., Valen, G., Baysa, A., Massimino, M. L., Sorgato, M. C., Bertoli, A., and Di Lisa, F. (2014) The cellular prion protein counteracts cardiac oxidative stress. Cardiovasc. Res. 104, 93-102
15. Strom, A., Wang, G. S., and Scott, F. W. (2011) Impaired glucose tolerance in mice lacking cellular prion protein. Pancreas 40, 229-232
16. Lopes, M. H., and Santos, T. G. (2012) Prion potency in stem cells biology. Prion 6, 142-146
17. Miranda, A., Ramos-Ibeas, P., Pericuesta, E., Ramirez, M. A., and Gutierrez-Adan, A. (2013) The role of prion protein in stem cell regulation. Reproduction 146, R91-R99
18. Petrakis, S., Irinopoulou, T., Panagiotidis, C. H., Engelstein, R., Lindstrom, J., Orr-Urtreger, A., Gabizon, R., Grigoriadis, N., and Sklaviadis, T. (2008) Cellular prion protein co-localizes with nAChR β4 subunit in brain and gastrointestinal tract. Eur. J. Neurosci. 27, 612-620
19. Beraldo, F. H., Arantes, C. P., Santos, T. G., Machado, C. F., Roffe, M., Hajj, G. N., Lee, K. S., Magalhães, A. C., Caetano, F. A., Mancini, G. L., Lopes, M. H., Américo, T. A., Magdesian, M. H., Ferguson, S. S., Linden, R., Prado, M. A., and Martins, V. R. (2011) Metabotropic glutamate receptors transduce signals for neurite outgrowth after binding of the prion protein to laminin γ1 chain. FASEB J. 25, 265-279
20. Beraldo, F. H., Arantes, C. P., Santos, T. G., Queiroz, N. G., Young, K., Rylett, R. J., Markus, R. P., Prado, M. A., and Martins, V. R. (2010) Role of α7 nicotinic acetylcholine receptor in calcium signaling induced by prion protein interaction with stress-inducible protein 1. J. Biol. Chem. 285, 36542-36550
21. Black, S. A., Stys, P. K., Zamponi, G. W., and Tsutsui, S. (2014) Cellular prion protein and NMDA receptor modulation: protecting against excitotoxicity. Front. Cell Dev. Biol. 2, 45
22. Rangel, A., Madroñal, N., Gruart, A., Gruart i Massó, A., Gavín, R., Llorens, F., Sumoy, L., Torres, J. M., Delgado-García, J. M., and Del Río, J. A. (2009) Regulation of GABA(A) and glutamate receptor expression, synaptic facilitation and long-term potentiation in the hippocampus of prion mutant mice. PLoS ONE 4, e7592
23. Mouillet-Richard, S., Pietri, M., Schneider, B., Vidal, C., Mutel, V., Launay, J. M., and Kellermann, O. (2005) Modulation of serotonergic receptor signaling and cross-talk by prion protein. J. Biol. Chem. 280, 4592-4601
24. Mouillet-Richard, S., Schneider, B., Pradines, E., Pietri, M., Ermonval, M., Grassi, J., Richards, J. G., Mutel, V., Launay, J. M., and Kellermann, O. (2007) Cellular prion protein signaling in serotonergic neuronal cells. Ann. N.Y. Acad. Sci. 1096, 106-119
25. Bassant, M. H., Fage, D., Dedek, J., Cathala, F., Court, L., and Scatton, B. (1984) Monoamine abnormalities in the brain of scrapie-infected rats. Brain Res. 308, 182-185
26. Vidal, C., Herzog, C., Haeberle, A. M., Bombarde, C., Miquel, M. C., Carimalo, J., Launay, J. M., Mouillet-Richard, S., Lasmézas, C., Dormont, D., Kellermann, O., and Bailly, Y. (2009) Early dysfunction of central 5-HT system in a murine model of bovine spongiform encephalopathy. Neuroscience 160, 731-743
27. Ledoux, J. M. (2005) Effects on the serotoninergic system in sub-acute transmissible spongiform encephalopathies: current data, hypotheses, suggestions for experimentation. Med. Hypotheses 64, 910-918
28. Cross, A. J., Kimberlin, R. H., Crow, T. J., Johnson, J. A., and Walker, C. A. (1985) Neurotransmitter metabolites, enzymes and receptors in experimental scrapie. J. Neurol. Sci. 70, 231-241
29. Adjou, K. T., Dilda, P., Aumond, P., Gueddari, S., Deslys, J. P., Dormont, D., and Seman, M. (2008) Increase of monoamine oxidase-B activity in the brain of scrapie-infected hamsters. Neurochem. Int. 52, 1416-1421
30. Rasenick, M. M., Valley, S., Manuelidis, E. E., and Manuelidis, L. (1986) Creutzfeldt-Jakob infection increases adenylate cyclase activity in specific regions of guinea pig brain. FEBS Lett. 198, 164-168
31. Wanschitz, J., Klöppel, S., Jarius, C., Birner, P., Flicker, H., Hainfellner, J. A., Gambetti, P., Guentchev, M., and Budka, H. (2000) Alteration of the serotonergic nervous system in fatal familial insomnia. Ann. Neurol. 48, 788-791
32. Ragno, M., Scarcella, M. G., Cacchiò, G., Capellari, S., Di Marzio, F., Parchi, P., and Trojano, L. (2009) Striatal [123I] FP-CIT SPECT demonstrates dopaminergic deficit in a sporadic case of Creutzfeldt-Jakob disease. Acta Neurolog. Scand. 119, 131-134
33. Magnin, E., Chopard, G., Galmiche, J., Brandel, J. P., and Rumbach, L. (2011) Unusual dopaminergic depletion in variant Creutzfeldt-Jakob disease with early and rapid cognitive decline. Eur. Neurol. 65, 368
34. Wall, C. A., Rummans, T. A., Aksamit, A. J., Krahn, L. E., and Pankratz, V. S. (2005) Psychiatric manifestations of Creutzfeldt-Jakob disease: a 25-year analysis. J. Neuropsychiatry Clin. Neurosci. 17, 489-495
35. Cumbler, E., Furfari, K., and Guerrasio, J. (2009) Creutzfeldt-Jacob disease presenting as severe depression: a case report. CASES J. 2, 122
36. Gadotti, V. M., Bonfield, S. P., and Zamponi, G. W. (2012) Depressive-like behaviour of mice lacking cellular prion protein. Behav. Brain Res. 227, 319-323
37. Laurén, J., Gimbel, D. A., Nygaard, H. B., Gilbert, J. W., and Strittmatter, S. M. (2009) Cellular prion protein mediates impairment of synaptic plasticity by amyloid-β oligomers. Nature 457, 1128-1132
38. Haass, C., and Selkoe, D. J. (2007) Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide. Nat. Rev. Mol. Cell Biol. 8, 101-112
39. Klein, W. L. (2013) Synaptotoxic amyloid-beta oligomers: a molecular basis for the cause, diagnosis, and treatment of Alzheimer's disease? J. Alzheimers Dis. 33, S49-S65
40. Ownby, R. L., Crocco, E., Acevedo, A., John, V., and Loewenstein, D. (2006) Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis. Arch. Gen. Psychiatry 63, 530-538
41. Green, R. C., Cupples, L. A., Kurz, A., Auerbach, S., Go, R., Sadovnick, D., Duara, R., Kukull, W. A., Chui, H., Edeki, T., Griffith, P. A., Friedland, R. P., Bachman, D., and Farrer, L. (2003) Depression as a risk factor for Alzheimer disease: the MIRAGE Study. Arch. Neurol. 60, 753-759
42. Khundakar, A. A., and Thomas, A. J. (2015) Neuropathology of depression in Alzheimer's disease: current knowledge and the potential for new treatments. J. Alzheimers Dis. 44, 27-41
43. Meeks, T. W., Ropacki, S. A., and Jeste, D. V. (2006) The neurobiology of neuropsychiatric syndromes in dementia. Curr. Opin. Psychiatry 19, 581-586
44. Vermeiren, Y., Van Dam, D., Aerts, T., Engelborghs, S., and De Deyn, P. P. (2014) Monoaminergic neurotransmitter alterations in postmortem brain regions of depressed and aggressive patients with Alzheimer's disease. Neurobiol. Aging 35, 2691-2700
45. Hirao, K., Pontone, G. M., and Smith, G. S. (2014) Molecular imaging of neuropsychiatric symptoms in Alzheimer's and Parkinson's disease. Neurosci. Biobehav. Rev. 49C, 157-170
46. Porsolt, R. D., Bertin, A., and Jalfre, M. (1977) Behavioral despair in mice: a primary screening test for antidepressants. Arch. Int. Pharmacodyn. Ther. 229, 327-336
47. Autry, A. E., Adachi, M., Nosyreva, E., Na, E. S., Los, M. F., Cheng, P. F., Kavalali, E. T., and Monteggia, L. M. (2011) NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses. Nature 475, 91-95
48. Steru, L., Chermat, R., Thierry, B., and Simon, P. (1985) The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology 85, 367-370
49. Posser, T., Kaster, M. P., Baraúna, S. C., Rocha, J. B., Rodrigues, A. L., and Leal, R. B. (2009) Antidepressant-like effect of the organoselenium compound ebselen in mice: evidence for the involvement of the monoaminergic system. Eur. J. Pharmacol. 602, 85-91
50. Gilman, A. G. (1970) A protein binding assay for adenosine 3′:5′-cyclic monophosphate. Proc. Natl. Acad. Sci. U.S.A. 67, 305-312
51. Arita, D. Y., Di Marco, G. S., Schor, N., and Casarini, D. E. (2002) Purification and characterization of the active form of tyrosine hydroxylase from mesangial cells in culture. J. Cell Biochem. 87, 58-64
52. Yan, H. C., Cao, X., Das, M., Zhu, X. H., and Gao, T. M. (2010) Behavioral animal models of depression. Neurosci. Bull. 26, 327-337
53. Dulawa, S. C., and Hen, R. (2005) Recent advances in animal models of chronic antidepressant effects: the novelty-induced hypophagia test. Neurosci. Biobehav. Rev. 29, 771-783
54. Gainetdinov, R. R., Premont, R. T., Bohn, L. M., Lefkowitz, R. J., and Caron, M. G. (2004) Desensitization of G protein-coupled receptors and neuronal functions. Annu. Rev. Neurosci. 27, 107-144
55. Salès, N., Rodolfo, K., Hässig, R., Faucheux, B., Di Giamberardino, L., and Moya, K. L. (1998) Cellular prion protein localization in rodent and primate brain. Eur. J. Neurosci. 10, 2464-2471
56. Lobão-Soares, B., Walz, R., Prediger, R. D., Freitas, R. L., Calvo, F., Bianchin, M. M., Leite, J. P., Landemberger, M. C., and Coimbra, N. C. (2008) Cellular prion protein modulates defensive attention and innate fear-induced behaviour evoked in transgenic mice submitted to an agonistic encounter with the tropical coral snake Oxyrhopus guibei. Behav. Brain Res. 194, 129-137
57. Roesler, R., Walz, R., Quevedo, J., de-Paris, F., Zanata, S. M., Graner, E., Izquierdo, I., Martins, V. R., and Brentani, R. R. (1999) Normal inhibitory avoidance learning and anxiety, but increased locomotor activity in mice devoid of PrP(C). Brain Res. Mol. Brain Res. 71, 349-353
58. Büeler, H., Fischer, M., Lang, Y., Bluethmann, H., Lipp, H. P., DeArmond, S. J., Prusiner, S. B., Aguet, M., and Weissmann, C. (1992) Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature 356, 577-582
59. Cowin, R. M., Bui, N., Graham, D., Green, J. R., Grueninger, S., Yuva- Paylor, L. A., Syed, A. U., Weiss, A., and Paylor, R. (2011) Onset and progression of behavioral and molecular phenotypes in a novel congenic R6/2 line exhibiting intergenerational CAG repeat stability. PLoS ONE 6, e28409
60. Nazor, K. E., Seward, T., and Telling, G. C. (2007) Motor behavioral and neuropathological deficits in mice deficient for normal prion protein expression. Biochim. Biophys. Acta 1772, 645-653
61. Massimino, M. L., Peggion, C., Loro, F., Stella, R., Megighian, A., Scorzeto, M., Blaauw, B., Toniolo, L., Sorgato, M. C., Reggiani, C., and Bertoli, A. (2015) Age-dependent neuromuscular impairment in prion protein knock-out mice. Muscle Nerve 10.1002/mus.24708
62. Coitinho, A. S., Roesler, R., Martins, V. R., Brentani, R. R., and Izquierdo, I. (2003) Cellular prion protein ablation impairs behavior as a function of age. Neuroreport 14, 1375-1379
63. Gasperini, L., and Legname, G. (2014) Prion protein and aging. Front. Cell Dev. Biol. 2, 44
64. Massimino, M. L., Redaelli, M., Bertoli, A., Sorgato, M. C., and Mucignat- Caretta, C. (2013) Altered behavioral aspects of aged mice lacking the cellular prion protein. Physiol. Behav. 119, 86-91
65. Can, A., Dao, D. T., Arad, M., Terrillion, C. E., Piantadosi, S. C., and Gould, T. D. (2012) The mouse forced swim test. J. Visual Exp. 29, e3638
66. Võikar, V., Kõks, S., Vasar, E., and Rauvala, H. (2001) Strain and gender differences in the behavior of mouse lines commonly used in transgenic studies. Physiol. Behav. 72, 271-281
67. Can, A., Blackwell, R. A., Piantadosi, S. C., Dao, D. T., O'Donnell, K. C., and Gould, T. D. (2011) Antidepressant-like responses to lithium in genetically diverse mouse strains. Genes Brain Behav. 10, 434-443
68. Wong, M. L., and Licinio, J. (2001) Research and treatment approaches to depression. Nat. Rev. Neurosci. 2, 343-351
69. Nikolaus, S., Antke, C., and Müller, H. W. (2009) In vivo imaging of synaptic function in the central nervous system: II. mental and affective disorders. Behav. Brain Res. 204, 32-66
70. Zarate, C., Duman, R. S., Liu, G., Sartori, S., Quiroz, J., and Murck, H. (2013) New paradigms for treatment-resistant depression. Ann. N.Y. Acad. Sci. 1292, 21-31
71. Krishnadas, R., and Cavanagh, J. (2012) Depression: an inflammatory illness? J. Neurol. Neurosurg. Psychiatry 83, 495-502
72. Berton, O., and Nestler, E. J. (2006) New approaches to antidepressant drug discovery: beyond monoamines. Nat. Rev. Neurosci. 7, 137-151
73. Perona, M. T., Waters, S., Hall, F. S., Sora, I., Lesch, K. P., Murphy, D. L., Caron, M., and Uhl, G. R. (2008) Animal models of depression in dopamine, serotonin, and norepinephrine transporter knockout mice: prominent effects of dopamine transporter deletions. Behav. Pharmacol. 19, 566-574
74. Lehmann, I. T., Bobrovskaya, L., Gordon, S. L., Dunkley, P. R., and Dickson, P. W. (2006) Differential regulation of the human tyrosine hydroxylase isoforms via hierarchical phosphorylation. J. Biol. Chem. 281, 17644-17651
75. Niciu, M. J., Ionescu, D. F., Mathews, D. C., Richards, E. M., and Zarate, C. A., Jr. (2013) Second messenger/signal transduction pathways in major mood disorders: moving from membrane to mechanism of action, part I: major depressive disorder. CNS Spectrums 18, 231-241
76. Beaulieu, J. M., and Gainetdinov, R. R. (2011) The physiology, signaling, and pharmacology of dopamine receptors. Pharmacol. Rev. 63, 182-217
77. Pei, L., Li, S., Wang, M., Diwan, M., Anisman, H., Fletcher, P. J., Nobrega, J. N., and Liu, F. (2010) Uncoupling the dopamine D1-D2 receptor complex exerts antidepressant-like effects. Nat. Med. 16, 1393-1395
78. Leggio, G. M., Salomone, S., Bucolo, C., Platania, C., Micale, V., Caraci, F., and Drago, F. (2013) Dopamine D3 receptor as a new pharmacological target for the treatment of depression. Eur. J. Pharmacol. 719, 25-33
79. Barnes, N. M., and Sharp, T. (1999) A review of central 5-HT receptors and their function. Neuropharmacology 38, 1083-1152
80. Carson, M. J., Thomas, E. A., Danielson, P. E., and Sutcliffe, J. G. (1996) The 5HT5A serotonin receptor is expressed predominantly by astrocytes in which it inhibits cAMP accumulation: a mechanism for neuronal suppression of reactive astrocytes. Glia 17, 317-326
81. Francken, B. J., Jurzak, M., Vanhauwe, J. F., Luyten, W. H., and Leysen, J. E. (1998) The human 5-HT5A receptor couples to Gi /Go proteins and inhibits adenylate cyclase in HEK 293 cells. Eur. J. Pharmacol. 361, 299-309
82. Hurley, P. T., McMahon, R. A., Fanning, P., O'Boyle, K. M., Rogers, M., and Martin, F. (1998) Functional coupling of a recombinant human 5-HT5A receptor to G-proteins in HEK-293 cells. Br. J. Pharmacol. 124, 1238-1244
83. Thomas, E. A., Matli, J. R., Hu, J. L., Carson, M. J., and Sutcliffe, J. G. (2000) Pertussis toxin treatment prevents 5-HT(5a) receptor-mediated inhibition of cyclic AMP accumulation in rat C6 glioma cells. J. Neurosci. Res. 61, 75-81
84. Noda, M., Yasuda, S., Okada, M., Higashida, H., Shimada, A., Iwata, N., Ozaki, N., Nishikawa, K., Shirasawa, S., Uchida, M., Aoki, S., and Wada, K. (2003) Recombinant human serotonin 5A receptors stably expressed in C6 glioma cells couple to multiple signal transduction pathways. J. Neurochem. 84, 222-232
85. Plassat, J. L., Boschert, U., Amlaiky, N., and Hen, R. (1992) The mouse 5HT5 receptor reveals a remarkable heterogeneity within the 5HT1D receptor family. EMBO J. 11, 4779-4786
86. Goodfellow, N. M., Bailey, C. D., and Lambe, E. K. (2012) The native serotonin 5-HT(5A) receptor: electrophysiological characterization in rodent cortex and 5-HT(1A)-mediated compensatory plasticity in the knock-out mouse. J. Neurosci. 32, 5804-5809
87. Kassai, F., Schlumberger, C., Kedves, R., Pietraszek, M., Jatzke, C., Lendvai, B., Gyertyán, I., and Danysz, W. (2012) Effect of 5-HT5A antagonists in animal models of schizophrenia, anxiety and depression. Behav. Pharmacol. 23, 397-406
88. Giese, K. P., and Mizuno, K. (2013) The roles of protein kinases in learning and memory. Learn. Mem. 20, 540-552
89. Gonzalez, R., Chávez-Pascacio, K., and Meneses, A. (2013) Role of 5-HT5A receptors in the consolidation of memory. Behav. Brain Res. 252, 246-251
90. Thomas, D. R., Soffin, E. M., Roberts, C., Kew, J. N., de la Flor, R. M., Dawson, L. A., Fry, V. A., Coggon, S. A., Faedo, S., Hayes, P. D., Corbett, D. F., Davies, C. H., and Hagan, J. J. (2006) SB-699551-A (3-cyclopentyl- N-[2-(dimethylamino)ethyl]-N-[(4′-{[(2-phenylethyl)amino]methyl}-4- biphenylyl)methyl]propanamide dihydrochloride), a novel 5-ht5A receptor-selective antagonist, enhances 5-HT neuronal function: evidence for an autoreceptor role for the 5-ht5A receptor in guinea pig brain. Neuropharmacology 51, 566-577
91. Rieger, R., Edenhofer, F., Lasmézas, C. I., and Weiss, S. (1997) The human 37-kDa laminin receptor precursor interacts with the prion protein in eukaryotic cells. Nat. Med. 3, 1383-1388
92. Graner, E., Mercadante, A. F., Zanata, S. M., Forlenza, O. V., Cabral, A. L., Veiga, S. S., Juliano, M. A., Roesler, R., Walz, R., Minetti, A., Izquierdo, I., Martins, V. R., and Brentani, R. R. (2000) Cellular prion protein binds laminin and mediates neuritogenesis. Brain Res. Mol. Brain Res. 76, 85-92
93. Zanata, S. M., Lopes, M. H., Mercadante, A. F., Hajj, G. N., Chiarini, L. B., Nomizo, R., Freitas, A. R., Cabral, A. L., Lee, K. S., Juliano, M. A., de Oliveira, E., Jachieri, S. G., Burlingame, A., Huang, L., Linden, R., Brentani, R. R., and Martins, V. R. (2002) Stress-inducible protein 1 is a cell surface ligand for cellular prion that triggers neuroprotection. EMBO J. 21, 3307-3316
94. Schmitt-Ulms, G., Legname, G., Baldwin, M. A., Ball, H. L., Bradon, N., Bosque, P. J., Crossin, K. L., Edelman, G. M., DeArmond, S. J., Cohen, F. E., and Prusiner, S. B. (2001) Binding of neural cell adhesion molecules (N-CAMs) to the cellular prion protein. J. Mol. Biol. 314, 1209-1225
95. Um, J. W., Kaufman, A. C., Kostylev, M., Heiss, J. K., Stagi, M., Takahashi, H., Kerrisk, M. E., Vortmeyer, A., Wisniewski, T., Koleske, A. J., Gunther, E. C., Nygaard, H. B., and Strittmatter, S. M. (2013) Metabotropic glutamate receptor 5 is a coreceptor for Alzheimer abeta oligomer bound to cellular prion protein. Neuron 79, 887-902
96. Clinton, J., Forsyth, C., Royston, M. C., and Roberts, G. W. (1993) Synaptic degeneration is the primary neuropathological feature in prion disease: a preliminary study. Neuroreport 4, 65-68
97. Senatore, A., Restelli, E., and Chiesa, R. (2013) Synaptic dysfunction in prion diseases: a trafficking problem? Int. J. Cell Biol. 2013, 543803
98. Caiati, M. D., Safiulina, V. F., Fattorini, G., Sivakumaran, S., Legname, G., and Cherubini, E. (2013) PrPC controls via protein kinase A the direction of synaptic plasticity in the immature hippocampus. J. Neurosci. 33, 2973-2983
99. Coitinho, A. S., Freitas, A. R., Lopes, M. H., Hajj, G. N., Roesler, R., Walz, R., Rossato, J. I., Cammarota, M., Izquierdo, I., Martins, V. R., and Brentani, R. R. (2006) The interaction between prion protein and laminin modulates memory consolidation. Eur. J. Neurosci. 24, 3255-3264
100. Berr, C., Helbecque, N., Sazdovitch, V., Mohr, M., Amant, C., Amouyel, P., Alpérovitch, A., and Hauw, J. J. (2003) Polymorphism of the codon 129 of the prion protein (PrP) gene and neuropathology of cerebral ageing. Acta Neuropathol. 106, 71-74
101. Croes, E. A., Dermaut, B., Houwing-Duistermaat, J. J., Van den Broeck, M., Cruts, M., Breteler, M. M., Hofman, A., van Broeckhoven, C., and van Duijn, C. M. (2003) Early cognitive decline is associated with prion protein codon 129 polymorphism. Ann. Neurol. 54, 275-276
102. Thompson, A., MacKay, A., Rudge, P., Lukic, A., Porter, M. C., Lowe, J., Collinge, J., and Mead, S. (2014) Behavioral and psychiatric symptoms in prion disease. Am. J. Psychiatry 171, 265-274
103. Baumgarten, H. G., and Lachenmayer, L. (2004) Serotonin neurotoxins: past and present. Neurotox. Res. 6, 589-614
104. Cools, R., Roberts, A. C., and Robbins, T. W. (2008) Serotoninergic regulation of emotional and behavioural control processes. Trends Cogn. Sci. 12, 31-40
105. Gimbel, D. A., Nygaard, H. B., Coffey, E. E., Gunther, E. C., Laurén, J., Gimbel, Z. A., and Strittmatter, S. M. (2010) Memory impairment in transgenic Alzheimer mice requires cellular prion protein. J. Neurosci. 30, 6367-6374
106. Ledo, J. H., Azevedo, E. P., Clarke, J. R., Ribeiro, F. C., Figueiredo, C. P., Foguel, D., De Felice, F. G., and Ferreira, S. T. (2013) Amyloid-β oligomers link depressive-like behavior and cognitive deficits in mice. Mol. Psychiatry 18, 1053-1054
107. Manson, J. C., Clarke, A. R., Hooper, M. L., Aitchison, L., McConnell, I., and Hope, J. (1994) 129/Ola mice carrying a null mutation in PrP that abolishes mRNA production are developmentally normal. Mol. Neurobiol. 8, 121-127